InvestSMART

Vitasora Health Limited (ASX:VHL)

ALERT: Price-sensitive ASX Announcement for VHL
Current share price for VHL : $0.013 0.003 (23.81%)+
Announcement
Release
11 Jun 2026 9:24AM
Price at Release
$0.011
Full Release
download
Summary
Vitasora Health Limited announced it has raised $4.0 million through a successful share placement, significantly exceeding its original target due to strong investor demand. The placement was cornerstoned by a $3.0 million strategic investment from private investor Bob Peters, who will become a substantial holder in the company. The directors also intend to subscribe for additional shares, subject to shareholder approval. The capital raised will facilitate the commercialization and expansion of the vCare EMR platform, aiming for cashflow breakeven by the second half of 2026. Vitasora is experiencing substantial growth in billings, which have increased by 70% since April 2026, and focuses on AI-driven healthcare solutions for chronic disease management.
Key Points
  • Vitasora Health Limited raised $4.0 million through a placement, exceeding its original target of $1.5 million.
  • The placement was strongly supported and closed at approximately 2.7 times the company’s initial goal, underscoring strong investor demand.
  • Bob Peters, a private investor, contributed $3.0 million as a strategic investment, becoming a substantial holder in the company.
  • The directors plan to subscribe for up to an additional $250,000 in new shares, pending shareholder approval.
  • The funds raised will be used to support the commercialization and scaling of Vitasora’s vCare EMR platform and to achieve monthly cashflow breakeven.
  • Vitasora is experiencing rapid growth, with monthly billings increasing 70% since April 2026.
  • The company is focused on AI-powered connected care and chronic disease management solutions.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.